TITLE

Chapter 2: Pharmacological cholesterol-lowering treatment in adults

PUB. DATE
November 2013
SOURCE
Kidney International Supplement;Nov2013, Vol. 3 Issue 3, p271
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article reflects on the cholesterol-lowering treatment in adults with the help of pharmacological interventions to reduce morbidity and mortality from atherosclerosis. Topics include reduction of risk of adverse cardiovascular events in chronic kidney disease (CKD) populations with the help of regimens including a statin, association of low density lipoprotein cholesterol (LDL-C) with atherosclerotic events, and association of LDL-C and coronary artery disease in dialysis patients.
ACCESSION #
17666050

 

Related Articles

  • Chapter 2: Pharmacological cholesterol-lowering treatment in adults.  // Kidney International Supplements;Nov2013, Vol. 3 Issue 3, p271 

    The article reflects on the cholesterol-lowering treatment in adults with the help of pharmacological interventions to reduce morbidity and mortality from atherosclerosis. Topics include reduction of risk of adverse cardiovascular events in chronic kidney disease (CKD) populations with the help...

  • Chapter 3: Assessment of lipid status in children with CKD.  // Kidney International Supplements;Nov2013, Vol. 3 Issue 3, p280 

    The article presents information on a study related to children with newly identified chronic kidney disease (CDK) and recommends evaluation with a lipid profile. Topics include prediction of lipid levels in children for future cardiovascular events, relationship between dyslipidemias and...

  • Chapter 4: Pharmacological cholesterol-lowering treatment in children.  // Kidney International Supplements;Nov2013, Vol. 3 Issue 3, p282 

    The article presents information on the pharmacological cholesterol-lowering treatment in children less than 18 years of age with chronic kidney disease (CKD) and suggests not to initiate the treatment with statins. Topics include trials of dyslipidemias, nutrition and dietary counseling, and...

  • Chapter 5: Triglyceride-lowering treatment in adults.  // Kidney International Supplements;Nov2013, Vol. 3 Issue 3, p284 

    The article presents information on a study related to triglyceride-lowering treatment in adults with chronic kidney disease (CKD) and hypertriglyceridemia and recommends therapeutic lifestyle change (TLC). Topics include non-pharmacological treatment such as dietary modification, weight...

  • Chapter 1: Assessment of lipid status in adults with CKD.  // Kidney International Supplements;Nov2013, Vol. 3 Issue 3, p268 

    The article presents information on a study related to the assessment of lipid status in adults with chronic kidney disease (CKD) and recommends evaluation with a lipid profile. Topics include determinants of dyslipidemia in CKD including glomerular filtration rate (GFR), diabetes mellitus, and...

  • Lipoprotein(a): Why is it important? Saeedi, Ramesh; Min Li; Frohlich, Jiri // British Columbia Medical Journal;May2014, Vol. 56 Issue 4, p180 

    Elevated lipoprotein(a) is an independent risk factor for cardiovascular disease, particularly in individuals with elevated low-density-lipoprotein cholesterol. Candidates for lipoprotein(a) screening include patients with familial hypercholesterolemia, those with personal or family history of...

  • Statins: The cause of much confusion. Hummerston, Gemma // British Journal of Cardiac Nursing;Jul2014, Vol. 9 Issue 7, p317 

    The author talks about the British National Institute for Health and Care Excellence draft on statin prescription and the debates that followed it because of the changes. She discusses the tweet she sent out from the "British Journal of Cardiac Nursing" Twitter account on the subject, and her...

  • LDL cholesterol levels in patients with coronary artery disease in real word: data from Cardiovascular Registry of Trieste. Cherubini, Antonella; Paolmba, Andrea; Morosin, Marco; Russo, Giulia; Mazzone, Carmine; Fisicaro, Maurizio; Barbati, Giulia; Stellato, Kira; Cioffi, Gianni; Tarantini, Luigi; Pulignano, Giovanni; Cattin, Luigi; Di Lenarda, Andrea // Cardiologia Croatica;May/Jun2014, Vol. 9 Issue 5/6, p247 

    Background: From the literature we know that less than 50% of patients with coronary artery disease (CAD) reaches the target LDL cholesterol <100 mg/dl in clinical practice. The 2012 European Guidelines on Prevention lowers the target to <70 mg/dl in very high risk patients. Methods: We analyzed...

  • Statins play a crucial role in the fight against coronary heart disease. Tatoulis, James // Journal of Pharmacy Practice & Research;Dec2013, Vol. 43 Issue 4, p332 

    A response by James Tatoulis to a letter to the editor about the article on the unbalanced reporting of the "Catalyst" program and exposure to unconventional views on coronary heart disease (CHD) and cholesterol is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics